Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Outset Medical (OM) Gains from Investment Securities (2018 - 2026)

Outset Medical has reported Gains from Investment Securities over the past 3 years, most recently at $4.4 million for Q1 2025.

Quarterly Gains from Investment Securities changed N/A to $4.4 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $81000.0 for FY2025, 11.96% down from the prior year.
Gains from Investment Securities was $4.4 million for Q1 2025 at Outset Medical, down from $8.9 million in the prior quarter.
Over five years, Gains from Investment Securities peaked at $4.4 million in Q1 2025 and troughed at $4.4 million in Q1 2025.